Head and Neck Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Head and Neck Tumor Clinical Trials and Studies

Recently Published Research from Norton Cancer Institute Head & Neck Tumor Program Physicians

Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma
Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors
Multifocal intradural extramedullary ependymoma, <em>MYCN</em> amplified: illustrative case
Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

Head and Neck Cancer Clinical Trials

Head and Neck Cancer Clinical Trials

Current Head and Neck Tumor Clinical Trials and Studies

Recently Published Research from Norton Cancer Institute Head & Neck Tumor Program Physicians

Related Stories

Cancer care medical assistant celebrates the past, looks forward to the future during Black History Month

Does HPV cause throat cancer?

How to prevent cervical cancer

Smoking causes cancer, no matter how many years you’ve been doing it

Schedule an Appointment